MedTrace Logo

Imaging Quantification of Inflammation (IQI)

NCT04704609 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-03-04

No results posted yet for this study

Summary

1\. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change.

Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.

Conditions

  • Uveitis

Interventions

OTHER

Standard of Care Imaging

We are collecting imaging that is standard of care for uveitis patients

Sponsors & Collaborators

  • Santen Inc.

    collaborator INDUSTRY

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Sunil K Srivastava, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-22
Primary Completion
2027-04-20
Completion
2027-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04704609 on ClinicalTrials.gov